Professional Medical Expertise Co.'s (ProMedEx) net profit grew 32% to SAR 12.1 million in the first half of 2024, compared to SAR 9.2 million in the previous year.
| Item | 6m 2023 | 6m 2024 | Change |
|---|---|---|---|
| Revenues | 118.81 | 149.43 | 25.8 % |
| Net Income | 9.16 | 12.11 | 32.1 % |
| Average Shares | 3.50 | 3.50 | - |
| EPS (Riyals) | 2.62 | 3.46 | 32.1 % |
The profit growth was driven by higher year-on-year (YoY) sales on large-value supply contracts during the first six months of 2024.
Total shareholders’ equity, no minority interest, reached SAR 99.33 million by June 30, 2024, compared to SAR 72.35 million a year earlier.
|
Historical Data |
|||
|
Period |
Revenues (SAR mln) |
Net Profit (SAR mln) |
EPS (SAR) |
|
H1 2022 |
73.85 |
5.18 |
5.52 |
|
H2 2022 |
102.20 |
13.84 |
3.95 |
|
H1 2023 |
118.81 |
9.16 |
2.62 |
|
H2 2023 |
131.31 |
15.68 |
4.48 |
|
H1 2024 |
149.43 |
12.10 |
3.46 |
Argaam Investment Company has updated the Privacy Policy of its services and digital platforms. Know more about our Privacy Policy here.
Argaam uses cookies to personalize content, to provide social media features and analyze traffic, that we might also share with third parties. You consent to our cookies if you use this website
Comments {{getCommentCount()}}
Be the first to comment
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}